摘要
原发性肺动脉高血压(primary pulmonary hypertension,PPH)是常发生于30岁～40岁之间的女性,且对这些患者而言是发病率及死亡率均很高的一种进行性加重疾病.
出处
《西南国防医药》
CAS
2002年第6期573-575,共3页
Medical Journal of National Defending Forces in Southwest China
参考文献18
-
1Rich S, Kaufmann E, Levy PS.The effect of high does of calcium ～ channel blockers on survival in patiente with primary pulnonary hypertension. N Engl Med, 1992; 327: 76～81
-
2Christman BW, Mcpherson CD, Newman JH, et al. An imbalance between the escretion of thrombosane and prostacyclin metabolites in pulmonary hypertension. N Engl Meb, 1992; 327:70～75
-
3Barst RJ, Rubin LJ, Long wa, et al. A comparison of contin uous intravenous epoprostenol (ptostacyclin) with convention al therapy for primary pulmonary hypertension: The primary pulnonary hypertension study group. N Engl J Med, 1996;334:296 ～ 302
-
4Badesch DB, Tapson VF, McGoon MD, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern MED, 2000; 132:435～434
-
5Hoeper MM, Schwarze M, Ehlerding S, et al. Long～ treat mant of primary yulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med, 2000; 342: 1866
-
6McLaughlin VV, Hess DM, Sigman J, et al. Long ～ term effects of UT ～ 15 on hemodynamics and esercise tolerance inprimary pulmonary hypertensiono Eur Respir J, 2000; 16: 394
-
7Nagaya N, Uematsu M, Okano Y, etal. Effect of orally ac tive prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. J Amcoll Cardiol, 1999; 34: 1188
-
8Giaid A, Saleh D.Reduced espression of endothelial nitric o side synthase in the lungs of patients with pulmonary hyperten sion. N Engl J Med, 1995; 333:214
-
9Chqannick RN, Newhart JW, Johnson FW, et al. Pulsed de livery of inhaled nitric oside to patients with primary pulmonary hypertension: an ambulatory deivery systerm and initial clini cal tests. Chest, 1996; 109:1545
-
10Giaid A, Yanagisawa M, Langleben D, etal. Espression of endothelin ～ 1 in the lungs of patients with pulmonary hyper tension. N Engl J Med, 1993; 328:1732
-
1杨起鹏.长期使用前列环素降低肺血管阻力治疗原发性肺动脉高血压[J].岭南心血管病杂志,1998,4(4):233-233.
-
2张隽,王辰.扩血管药物治疗原发性肺动脉高压[J].临床药物治疗杂志,2003,1(4):39-41. 被引量：1
-
3孙怀志.原发性肺动脉高压二例误诊分析[J].临床误诊误治,2009,22(2):68-68. 被引量：1
-
4边长勇,秦永文,郑兴,丁继军,赵仙先.原发性肺动脉高压16例临床分析[J].第二军医大学学报,2002,23(7):809-810.
-
5程训民,余波,何国祥.原发性肺动脉高压的诊断与治疗进展[J].临床心血管病杂志,2003,19(5):312-314. 被引量：4
-
6高元明,商鸣宇.原发性肺动脉高压治疗进展[J].中华结核和呼吸杂志,2003,26(9):563-564. 被引量：5
-
7金露.何立人治疗原发性肺动脉高压经验[J].吉林中医药,2008,28(5):324-325. 被引量：2
-
8周艳荣,周同甫.肺动脉高压的遗传机制研究进展[J].华西医学,2009,24(1):223-225. 被引量：3
-
9荆志成,王辰,程显声.原发性肺动脉高压病因及发病机制研究进展[J].中华医学杂志,2003,83(1):77-79. 被引量：7
-
10周淑娴,张玉玲,周艳,雷娟.原发性肺动脉高压10例的诊治[J].岭南心血管病杂志,2006,12(4):254-257.
